Lipidomics: Novel insight into the biochemical mechanism of lipid metabolism and dysregulation-associated disease

Chemico-Biological Interactions

Volumn 240, Issue , 2015, Pages 220-238

  Zhao, Ying Yong ^a   Miao, Hua ^a   Cheng, Xian Long ^b   Wei, Feng ^b  

^a NORTHWEST UNIVERSITY   (China)

^b NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

Author keywords

Biomarker; Lipid profiling; Lipidomics; Liquid chromatography; Mass spectrometry

Indexed keywords

FATTY ACID; GLYCEROLIPID; GLYCEROPHOSPHOLIPID; LIPID; LIPIDOME; MONOUNSATURATED FATTY ACID; POLYKETIDE; POLYUNSATURATED FATTY ACID; PRENOL; SACCHAROLIPID; SPHINGOLIPID; STEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ALZHEIMER DISEASE; ANALYTIC METHOD; BIOCHEMISTRY; BRAIN INJURY; BREAST CANCER; CAPILLARY ELECTROPHORESIS; CARDIOVASCULAR DISEASE; COLORECTAL CANCER; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE MARKER; DISORDERS OF LIPID METABOLISM; ELECTROSPRAY MASS SPECTROMETRY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; INFECTION; LIPID ANALYSIS; LIPID METABOLISM; LIPIDOMICS; LIQUID CHROMATOGRAPHY; MALIGNANT NEOPLASTIC DISEASE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLIC DISORDER; METABOLIC SYNDROME X; METABOLOMICS; NERVE DEGENERATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OBESITY; OVARY CANCER; PARKINSON DISEASE; PATHOGENESIS; PROSTATE CANCER; PROTEOMICS; QUANTITATIVE ANALYSIS; RESPIRATORY TRACT DISEASE; REVIEW; SCHIZOPHRENIA; SUPERCRITICAL FLUID CHROMATOGRAPHY; THIN LAYER CHROMATOGRAPHY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; BRAIN CHEMISTRY; CHEMISTRY; MOUSE; PATHOPHYSIOLOGY;

ANIMALS; BIOMARKERS; BRAIN CHEMISTRY; BRAIN INJURIES; HUMANS; LIPID METABOLISM; LIPIDS; MICE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84941281788     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2015.09.005     Document Type: Review

References (182)

1. X. Han, and R.W. Gross Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics J. Lipid Res. 44 2003 1071 1079
2. F. Spener, M. Lagarde, A. Geloen, and M. Record What is lipidomics? Eur. J. Lipid Sci. Technol. 105 2003 481 482
3. E. Fahy, S. Subramaniam, H.A. Brown, C.K. Glass, A.H. Merrill Jr., R.C. Murphy, C.R. Raetz, D.W. Russell, Y. Seyama, W. Shaw, T. Shimizu, F. Spener, G. van Meer, M.S. Van Nieuwenhze, S.H. White, J.L. Witztum, and E.A. Dennis A comprehensive classification system for lipids J. Lipid Res. 46 2005 839 861
4. S. Subramaniam, E. Fahy, S. Gupta, M. Sud, R.W. Byrnes, D. Cotter, A.R. Dinasarapu, and M.R. Maurya Bioinformatics and systems biology of the lipidome Chem. Rev. 111 2011 6452 6490
5. H.A. Brown, and R.C. Murphy Working towards an exegesis for lipids in biology Nat. Chem. Biol. 5 2009 602 606
6. C. Hu, R. van der Heijden, M. Wang, J. van der Greef, T. Hankemeier, and G. Xu Analytical strategies in lipidomics and applications in disease biomarker discovery J. Chromatogr. B 877 2009 2836 2846
7. K. Sandra, and P. Sandra Lipidomics from an analytical perspective Curr. Opin. Chem. Biol. 17 2013 847 853
8. N. Navas-Iglesias, A. Carrasco-Pancorbo, and L. Cuadros-Rodríguez From lipids analysis towards lipidomics, a new challenge for the analytical chemistry of the 21st century. Part II: analytical lipidomics TrAC Trend Anal. Chem. 28 2009 393 403
9. Y.Y. Zhao, X.L. Cheng, and R.C. Lin Lipidomics applications for discovering biomarkers of diseases in clinical chemistry Int. Rev. Cell Mol. Biol. 313 2014 1 26
10. Y.Y. Zhao, X.L. Cheng, R.C. Lin, and F. Wei Lipidomics applications for diseases biomarker discovery in mammal models Biomark. Med. 9 2015 153 168
11. A.T. James, and A.J. Martin Gas-liquid chromatography: the separation and identification of the methyl esters of saturated and unsaturated acids from formic acid to n-octadecanoic acid Biochem. J. 63 1956 144 152
12. M.C. Thomas, T.W. Mitchell, D.G. Harman, J.M. Deeley, J.R. Nealon, and S.J. Blanksby Ozone-induced dissociation: elucidation of double bond position within mass-selected lipid ions Anal. Chem. 80 2008 303 311
13. F.F. Hsu, and J. Turk Electrospray ionization multiple-stage linear ion-trap mass spectrometry for structural elucidation of triacylglycerols: assignment of fatty acyl groups on the glycerol backbone and location of double bonds J. Am. Soc. Mass Spectrom. 21 2010 657 669
14. S.J. Blanksby, and T.W. Mitchell Advances in mass spectrometry for lipidomics Annul. Rev. Anal. Chem. 3 2010 433 465
15. Y.Y. Zhao, S.P. Wu, S. Liu, Y. Zhang, and R.C. Lin Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications Chem. Biol. Interact. 220 2014 181 192
16. W.J. Griffiths, and Y. Wang Mass spectrometry: from proteomics to metabolomics and lipidomics Chem. Soc. Rev. 38 2009 1882 1896
17. N. Goto-Inoue, T. Hayasaka, N. Zaima, and M. Setou Imaging mass spectrometry for lipidomics Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1811 2011 961 969
18. N. Zehethofer, and D.M. Pinto Recent developments in tandem mass spectrometry for lipidomic analysis Anal. Chim. Acta 627 2008 62 70
19. X. Han, K. Yang, and R.W. Gross Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses Mass Spectrom. Rev. 31 2012 134 178
20. X. Han, and R.W. Gross Shotgun lipidomics: multidimensional MS analysis of cellular lipidomes Expert Rev. Proteomics 2 2005 253 264
21. M. Wrona, T. Mauriala, K.P. Bateman, R.J. Mortishire-Smith, and D. O'Connor 'All-in-One' analysis for metabolite identification using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry with collision energy switching Rapid Commun. Mass Spectrom. 19 2005 2597 2602
22. K.P. Bateman, J. Castro-Perez, M. Wrona, J.P. Shockcor, K. Yu, R. Oballa, and D.A. Nicoll-Griffith MSE with mass defect filtering for in vitro and in vivo metabolite identification Rapid Commun. Mass Spectrom. 21 2007 1485 1496
23. N.E. Madala, P.A. Steenkamp, L.A. Piater, and I.A. Dubery Collision energy alteration during mass spectrometric acquisition is essential to ensure unbiased metabolomic analysis Anal. Bioanal. Chem. 404 2012 367 372
24. Y.Y. Zhao, and R.C. Lin UPLC-MSE application in disease biomarker discovery: the discoveries in proteomics to metabolomics Chem. Biol. Interact. 215 2014 7 16
25. H. Chen, H. Miao, Y.L. Feng, Y.Y. Zhao, and R.C. Lin Metabolomics in dyslipidemia Adv. Clin. Chem. 66 2014 101 119
26. Y.Y. Zhao, X.L. Cheng, F. Wei, X. Bai, and R.C. Lin Application of faecal metabonomics on an experimental model of tubulointerstitial fibrosis by ultra performance liquid chromatography/high-sensitivity mass spectrometry with MSE data collection technique Biomarkers 17 2012 721 729
27. Y.Y. Zhao, L. Zhang, F.Y. Long, X.L. Cheng, X. Bai, F. Wei, and R.C. Lin UPLC-Q-TOF/HSMS/MSE-based metabonomics for adenine-induced changes in metabolic profiles of rat faeces and intervention effects of ergosta-4,6,8(14),22-tetraen-3-one Chem. Biol. Interact. 301 2013 31 38
28. L. Imbert, M. Gaudin, D. Libong, D. Touboul, S. Abreu, P.M. Loiseau, O. Laprévote, and P. Chaminade Comparison of electrospray ionization, atmospheric pressure chemical ionization and atmospheric pressure photoionization for a lipidomic analysis of Leishmania donovani J. Chromatogr. A 1242 2012 75 83
29. Z. Takáts, J.M. Wiseman, and R.G. Cooks Ambient mass spectrometry using desorption electrospray ionization (DESI): instrumentation, mechanisms and applications in forensics, chemistry, and biology J. Mass Spectrom. 40 2005 1261 1275
30. H. Farwanah, T. Kolter, and K. Sandhoff Mass spectrometric analysis of neutral sphingolipids: methods, applications, and limitations Biochim. Biophys. Acta Mol. Cell. Biol. Lipids 1811 2011 854 860
31. H.Y. Wang, X. Chu, Z.X. Zhao, X.S. He, and Y.L. Guo Analysis of low molecular weight compounds by MALDI-FTICR-MS J. Chromatogr. B 879 2011 1166 1179
32. F.F. Hsu, S. Pacheco, J. Turk, and G. Purdy Structural determination of glycopeptidolipids of Mycobacterium smegmatis by high-resolution multiple-stage linear ion-trap mass spectrometry with electrospray ionization J. Mass Spectrom. 47 2012 1269 1281
33. J.A. Fernández, B. Ochoa, O. Fresnedo, M.T. Giralt, and R. Rodríguez-Puertas Matrix-assisted laser desorption ionization imaging mass spectrometry in lipidomics Anal. Bioanal. Chem. 401 2011 29 51
34. D. Touboul, H. Piednoël, V. Voisin, S. De La Porte, A. Brunelle, F. Halgand, and O. Laprévote Changes of phospholipid composition within the dystrophic muscle by matrix-assisted laser desorption/ionization mass spectrometry and mass spectrometry imaging Eur. J. Mass Spectrom. 10 2004 657 664
35. S.R. Shanta, L.H. Zhou, Y.S. Park, Y.H. Kim, Y. Kim, and K.P. Kim Binary matrix for MALDI imaging mass spectrometry of phospholipids in both ion modes Anal. Chem. 83 2011 1252 1259
36. P. Delmonte, A.R. Fardin, Kia, J.K. Kramer, M.M. Mossoba, L. Sidisky, and J.I. Rader Separation characteristics of fatty acid methyl esters using SLB-IL111, a new ionic liquid coated capillary gas chromatographic column J. Chromatogr. A 8 2011 545 554
37. P.Q. Tranchida, F.A. Franchina, P. Dugo, and L. Mondello A flow-modulated comprehensive gas chromatography-mass spectrometry method for the analysis of fatty acid profiles in marine and biological samples J. Chromatogr. A 1255 2012 171 176
38. S. Bogusz, L.W. Hantao Jr., S.C. Braga, C. de Matos França Vde, M.F. da Costa, R.D. Hamer, D.F. Ventura, and F. Augusto Solid-phase microextraction combined with comprehensive two-dimensional gas chromatography for fatty acid profiling of cell wall phospholipids J. Sep. Sci. 35 2012 2438 2444
39. R. Michael-Jubeli, J. Bleton, and A. Baillet-Guffroy Higherature gas chromatography-mass spectrometry for skin surface lipids profiling J. Lipid Res. 52 2011 143 151
40. R. Laaksonen, M.T. Janis, and M. Oresic Lipidomics-based safety biomarkers for lipid-lowering treatments Angiology 59 2008 65S 68S
41. M. Oresic, V.A. Hänninen, and A. Vidal-Puig Lipidomics: a new window to biomedical frontiers Trends Biotechnol. 26 2008 647 652
42. M. Sysi-Aho, J. Koikkalainen, T. Seppänen-Laakso, M. Kaartinen, J. Kuusisto, K. Peuhkurinen, S. Kärkkäinen, M. Antila, K. Lauerma, E. Reissell, R. Jurkko, J. Lötjönen, T. Heliö, and M. Orešič Serum lipidomics meets cardiac magnetic resonance imaging: profiling of subjects at risk of dilated cardiomyopathy Plos One 6 2011 e15744
43. L. Yetukuri, I. Huopaniemi, A. Koivuniemi, M. Maranghi, A. Hiukka, H. Nygren, S. Kaski, M.R. Taskinen, I. Vattulainen, M. Jauhiainen, and M. Orešič High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudy Plos One 6 2011 e23589
44. I.D. Wilson, J.K. Nicholson, J. Castro-Perez, J.H. Granger, K.A. Johnson, B.W. Smith, and R.S. Plumb High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies J. Proteome Res. 4 2005 591 598
45. H. Miao, H. Chen, S. Pei, S.M. Liu, X. Bai, and Y.Y. Zhao Plasma lipidomics reveal profound perturbation of glycerophospholipids, fatty acids, and sphingolipids in diet-induced hyperlipidemia Chem. Biol. Interact. 228 2014 79 87
46. Y.Y. Zhao, J. Liu, X.L. Cheng, X. Bai, and R.C. Lin Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS Clin. Chim. Acta 413 2012 642 649
47. Y.Y. Zhao, X. Shen, X.L. Cheng, F. Wei, X. Bai, and R.C. Lin Urinary metabonomics study on the protective effects of ergosta-4,6,8(14),22-tetraen-3-one on chronic renal failure in rats using UPLC Q-TOF/MS and a novel MSE data collection technique Process Biochem. 47 2012 1980 1987
48. Y.Y. Zhao, H.T. Li, Y.L. Feng, X. Bai, and R.C. Lin Urinary metabonomic study of the surface layer of poria cocos as an effective treatment for chronic renal injury in rats J. Ethnopharmacol. 148 2013 403 410
49. T. Bamba, J.W. Lee, A. Matsubara, and E. Fukusaki Metabolic profiling of lipids by supercritical fluid chromatography/mass spectrometry J. Chromatogr. A 1250 2012 212 219
50. T. Yamada, T. Uchikata, S. Sakamoto, Y. Yokoi, S. Nishiumi, M. Yoshida, E. Fukusaki, and T. Bamba Supercritical fluid chromatography/Orbitrap mass spectrometry based lipidomics platform coupled with automated lipid identification software for accurate lipid profiling J. Chromatogr. A 1301 2013 237 242
51. T. Uchikata, A. Matsubara, S. Nishiumi, M. Yoshida, E. Fukusaki, and T. Bamba Development of oxidized phosphatidylcholine isomer profiling method using supercritical fluid chromatography/tandem mass spectrometry J. Chromatogr. A 1250 2012 205 211
52. F. Gao, Z. Zhang, X. Fu, W. Li, T. Wang, and H. Liu Analysis of phospholipids by NACE with on-line ESI-MS Electrophoresis 28 2007 1418 1425
53. R. Jang, K.H. Kim, S.A. Zaidi, W.J. Cheong, and M.H. Moon Analysis of phospholipids using an open-tubular capillary column with a monolithic layer of molecularly imprinted polymer in capillary electrochromatography-electrospray ionization-tandem mass spectrometry Electrophoresis 32 2011 2167 2173
54. M. Kliman, J.C. May, and J.A. McLean Lipid analysis and lipidomics by structurally selective ion mobility-mass spectrometry Biochim. Biophys. Acta Mol. Cell. Boil. Lipids 1811 2011 935 945
55. D. Touboul, and M. Gaudin Lipidomics of Alzheimer's disease Bioanalysis 6 2014 541 561
56. G. Astarita, and D. Piomelli Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease Prostagl. Leukot. Essent. Fat. Acids 85 2011 197 203
57. X. Han Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease Biochim. Biophys. Acta Mol. Cell Boil. Lipids 1801 2010 774 783
58. M.N. Sabbagh, S. Sandhu, H. Kolody, T. Lahti, N.B. Silverberg, and D.L. Sparks Studies on the effect of the apolipoprotein E genotype on the lipid profile in Alzheimer's disease Curr. Alzheimer Res. 3 2006 157 160
59. M. Mapstone, A.K. Cheema, M.S. Fiandaca, X. Zhong, T.R. Mhyre, L.H. MacArthur, W.J. Hall, S.G. Fisher, D.R. Peterson, J.M. Haley, M.D. Nazar, S.A. Rich, D.J. Berlau, C.B. Peltz, M.T. Tan, C.H. Kawas, and H.J. Federoff Plasma phospholipids identify antecedent memory impairment in older adults Nat. Med. 20 2014 415 418
60. R.B. Chan, T.G. Oliveira, E.P. Cortes, L.S. Honig, K.E. Duff, S.A. Small, M.R. Wenk, G. Shui, and G. Di Paolo Comparative lipidomic analysis of mouse and human brain with Alzheimer disease J. Biol. Chem. 287 2012 2678 2688
61. X. Han, S. Rozen, S.H. Boyle, C. Hellegers, H. Cheng, J.R. Burke, K.A. Welsh-Bohmer, P.M. Doraiswamy, and R. Kaddurah-Daouk Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics Plos One 6 2011 e21643
62. L. Iuliano, A. Pacelli, M. Ciacciarelli, C. Zerbinati, S. Fagioli, F. Piras, M.D. Orfei, P. Bossù, F. Pazzelli, G. Serviddio, C. Caltagirone, and G. Spalletta Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer's disease J. Alzheimers Dis. 36 2013 545 553
63. H.N. Nguyen, D.J. Son, J.W. Lee, D.Y. Hwang, Y.K. Kim, J.S. Cho, U.S. Lee, H.S. Yoo, D.C. Moon, K.W. Oh, and J.T. Hong Mutant presenilin 2 causes abnormality in the brain lipid profile in the development of Alzheimer's disease Arch. Pharm. Res. 29 2006 884 889
64. Y.Y. Zhao, X.L. Cheng, N.D. Vaziri, S. Liu, and R.C. Lin UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry Clin. Biochem. 47 2014 16 26
65. T. Hartmann, J. Kuchenbecker, and M.O.W. Grimm Alzheimer's disease: the lipid connection J. Neurochem. 103 2007 159 170
66. D.E. Berman, C. Dall'Armi, S.V. Voronov, L.B. McIntire, H. Zhang, A.Z. Moore, A. Staniszewski, O. Arancio, T.W. Kim, and G. Di Paolo Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism Nat. Neurosci. 11 2008 547 554
67. M.J. Sharman, G. Shui, A.Z. Fernandis, W.L. Lim, T. Berger, E. Hone, K. Taddei, I.J. Martins, J. Ghiso, J.D. Buxbaum, S. Gandy, M.R. Wenk, and R.N. Martins Profiling brain and plasma lipids in human APOE epsilon2, epsilon3, and epsilon4 knock-in mice using electrospray ionization mass spectrometry J. Alzheimers Dis. 20 2010 105 111
68. T.G. Oliveira, R.B. Chan, H. Tian, M. Laredo, G. Shui, A. Staniszewski, H. Zhang, L. Wang, T.W. Kim, K.E. Duff, M.R. Wenk, O. Arancio, and G. Di Paolo Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits J. Neurosci. 30 2010 16419 16428
69. C. Chan, X. Qi, M.W. Li, F.L. Wong, and H.M. Lam Recent developments of genomic research in soybean J. Genet. Genomics 39 2012 317 324
70. J. Davignon, R.E. Gregg, and C.F. Sing Apolipoprotein E polymorphism and atherosclerosis Arteriosclerosis 8 1988 1 21
71. W.L. Lim, S.M. Lam, G. Shui, A. Mondal, D. Ong, X. Duan, R. Creegan, I.J. Martins, M.J. Sharman, K. Taddei, G. Verdile, M.R. Wenk, and R.N. Martins Effects of high-fat, high-cholesterol diet on brain lipid profiles in apolipoprotein E 33 and 34 knock-in mice Neurobiol. Aging 34 2013 221722 221724
72. Y. Zeng, H. Cheng, X. Jiang, and X. Han Endosomes and lysosomes play distinct roles in sulfatide-induced neuroblastoma apoptosis: Potential mechanisms contributing to abnormal sulfatide metabolism in related neuronal diseases Biochem. J. 410 2008 81 92
73. R.O. Sanchez-Mejia, J.W. Newman, S. Toh, G.Q. Yu, Y. Zhou, B. Halabisky, M. Cissé, K. Scearce-Levie, I.H. Cheng, L. Gan, J.J. Palop, J.V. Bonventre, and L. Mucke Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease Nat. Neurosci. 11 2008 1311 1318
74. W.P. Gai, H.X. Yuan, X.Q. Li, J.T. Power, P.C. Blumbergs, and P.H. Jensen In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies Exp. Neurol. 166 2000 324 333
75. G. Barceló-Coblijn, M.Y. Golovko, I. Weinhofer, J. Berger, and E.J. Murphy Brain neutral lipids mass is increased in alpha-synuclein gene-ablated mice J. Neurochem. 101 2007 132 141
76. I. Rappley, D.S. Myers, S.B. Milne, P.T. Ivanova, M.J. Lavoie, H.A. Brown, and D.J. Selkoe Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with α-synuclein genotype J. Neurochem. 111 2009 15 25
77. V. Ruipérez, F. Darios, and B. Davletov Alpha-synuclein, lipids and Parkinson's disease Prog. Lipid Res. 49 2009 420 428
78. D.A. Bosco, D.M. Fowler, Q. Zhang, J. Nieva, E.T. Powers, P. Wentworth, R.A. Lerner Jr., and J.W. Kelly Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization Nat. Chem. Biol. 2 2006 249 253
79. P. Bar-On, L. Crews, A.O. Koob, H. Mizuno, A. Adame, B. Spencer, and E. Masliah Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease J. Neurochem. 105 2008 1656 1667
80. M.G. Spillantini, M.L. Schmidt, V.M. Lee, J.Q. Trojanowski, R. Jakes, and M. Goedert Alpha-synuclein in Lewy bodies Nature 388 1997 839 840
81. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W.G. Johnson, A.M. Lazzarini, R.C. Duvoisin, G. Di Iorio, L.I. Golbe, and R.L. Nussbaum Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
82. R. Krüger, W. Kuhn, T. Müller, D. Woitalla, M. Graeber, S. Kösel, H. Przuntek, J.T. Epplen, L. Schöls, and O. Riess Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nat. Genet. 18 1988 106 108
83. J.J. Zarranz, J. Alegre, J.C. Gómez-Esteban, E. Lezcano, R. Ros, I. Ampuero, L. Vidal, J. Hoenicka, O. Rodriguez, B. Atarés, V. Llorens, E. Gomez Tortosa, T. del Ser, D.G. Muñoz, and J.G. de Yebenes The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Ann. Neurol. 55 2004 164 173
84. A.B. Singleton, M. Farrer, J. Johnson, A. Singleton, S. Hague, J. Kachergus, M. Hulihan, T. Peuralinna, A. Dutra, R. Nussbaum, S. Lincoln, A. Crawley, M. Hanson, D. Maraganore, C. Adler, M.R. Cookson, M. Muenter, M. Baptista, D. Miller, J. Blancato, J. Hardy, and K. Gwinn-Hardy Alpha-synuclein locus triplication causes Parkinson's disease Science 302 2003 841
85. P. Ibáñez, A.M. Bonnet, B. Débarges, E. Lohmann, F. Tison, P. Pollak, Y. Agid, A. Dürr, and A. Brice Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease Lancet 364 2004 1169 1171
86. E. Schwarz, S. Prabakaran, P. Whitfield, H. Major, F.M. Leweke, D. Koethe, P. McKenna, and S. Bahn High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and Ceramides J. Proteome Res. 7 2008 4266 4277
87. M. Orešič, T. Seppänen-Laakso, D. Sun, J. Tang, S. Therman, R. Viehman, U. Mustonen, T.G. van Erp, T. Hyötyläinen, P. Thompson, A.W. Toga, M.O. Huttunen, J. Suvisaari, J. Kaprio, J. Lönnqvist, and T.D. Cannon Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia Genome Med. 4 2012 1
88. J. McEvoy, R.A. Baillie, H. Zhu, P. Buckley, M.S. Keshavan, H.A. Nasrallah, G.G. Dougherty, J.K. Yao, and R. Kaddurah-Daouk Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics Plos One 8 2013 e68717
89. X. Zhou, J. Mao, J. Ai, Y. Deng, M.R. Roth, C. Pound, J. Henegar, R. Welti, and S.A. Bigler Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics Plos One 7 2012 e48889
90. K. Athenstaedt, and G. Daum Phosphatidic acid, a key intermediate in lipid metabolism. SourceInstitut für Biochemie, Technische Universität, Graz, Austria Eur. J. Biochem. 266 1999 1 16
91. X. Zhou, T.J. Lawrence, Z. He, C.R. Pound, J. Mao, and S.A. Bigler The expression level of lysophosphatidylcholine acyltransferase 1 (LPCAT1) correlates to the progression of prostate cancer Exp. Mol. Pathol. 92 2011 105 110
92. H.K. Min, S. Lim, B.C. Chung, and M.H. Moon Shotgun lipidomics for candidate biomarkers of urinary phospholipids in prostate cancer Anal. Bioanal. Chem. 399 2011 823 830
93. A. Llorente, T. Skotland, T. Sylvänne, D. Kauhanen, T. Róg, A. Orłowski, I. Vattulainen, K. Ekroos, and K. Sandvig Molecular lipidomics of exosomes released by PC-3 prostate cancer cells Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1831 2013 1302 1309
94. I.C. Kim, J.H. Lee, G. Bang, S.H. Choi, Y.H. Kim, K.P. Kim, H.K. Kim, and J. Ro Lipid profiles for HER2-positive breast cancer Anticancer Res. 33 2013 2467 2472
95. D. Luyimbazi, A. Akcakanat, P.F. McAuliffe, L. Zhang, G. Singh, A.M. Gonzalez-Angulo, H. Chen, K.A. Do, Y. Zheng, M.C. Hung, G.B. Mills, and F. Meric-Bernstam Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer Mol. Cancer Ther. 9 2010 2770 2784
96. B. Griffiths, C.A. Lewis, K. Bensaad, S. Ros, Q. Zhang, E.C. Ferber, S. Konisti, B. Peck, H. Miess, P. East, M. Wakelam, A.L. Harris, and A. Schulze Sterol regulatory element binding protein-dependent of lipid synthesis supports cell survival and tumour growth Cancer Metab. 1 2013 3
97. M. Kawashima, N. Iwamoto, N. Kawaguchi-Sakita, M. Sugimoto, T. Ueno, Y. Mikami, K. Terasawa, T.A. Sato, K. Tanaka, K. Shimizu, and M. Toi High-resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer Cancer Sci. 104 2013 1372 1379
98. J. Cimino, D. Calligaris, J. Far, D. Debois, S. Blacher, N.E. Sounni, A. Noel, and E. De Pauw Towards lipidomics of low-abundant species for exploring tumor heterogeneity guided by high-resolution mass spectrometry imaging Int. J. Mol. Sci. 14 2013 24560 24580
99. Y. Liu, Y. Chen, A. Momin, R. Shaner, E. Wang, N.J. Bowen, L.V. Matyunina, L.D. Walker, J.F. McDonald, M.C. Sullards, and A.H. Merrill Jr. Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry Mol. Cancer 9 2010 186
100. A.L. Dill, L.S. Eberlin, A.B. Costa, C. Zheng, D.R. Ifa, L. Cheng, T.A. Masterson, M.O. Koch, O. Vitek, and R.G. Cooks Multivariate statistical identification of human bladder carcinomas using ambient ionization imaging mass spectrometry Chemistry 17 2011 2897 2902
101. S. Guo, L. Qiu, Y. Wang, X. Qin, H. Liu, M. He, Y. Zhang, Z. Li, and X. Chen Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry Anal. Bioanal. Chem. 406 2014 4357 4370
102. F. Li, X. Qin, H. Chen, L. Qiu, Y. Guo, H. Liu, G. Chen, G. Song, X. Wang, F. Li, S. Guo, B. Wang, and Z. Li Lipid profiling for early diagnosis and progression of colorectal cancer using direct-infusion electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry Rapid Commun. Mass Spectrom. 27 2013 24 34
103. M.L. Dória, Z. Cotrim, B. Macedo, C. Simões, P. Domingues, L. Helguero, and M.R. Domingues Lipidomic approach to identify patterns in phospholipid profiles and define class differences in mammary epithelial and breast cancer cells Breast Cancer Res. Treat. 133 2012 635 648
104. M.L. Dória, C.Z. Cotrim, C. Simões, B. Macedo, P. Domingues, M.R. Domingues, and L.A. Helguero Lipidomic analysis of phospholipids from human mammary epithelial and breast cancer cell lines J. Cell Physiol. 228 2013 457 468
105. Y.Y. Zhao, and R.C. Lin Metabolomics in nephrotoxicity Adv. Clin. Chem. 65 2014 69 89
106. A.L. Dill, L.S. Eberlin, C. Zheng, A.B. Costa, D.R. Ifa, L. Cheng, T.A. Masterson, M.O. Koch, O. Vitek, and R.G. Cooks Multivariate statistical differentiation of renal cell carcinomas based on lipidomic analysis by ambient ionization imaging mass spectrometry Anal. Bioanal. Chem. 398 2010 2969 2978
107. L. Zhang, B.L. Peterson, and B.S. Cummings The effect of inhibition of Ca2+-independent phospholipase A2 on chemotherapeutic-induced death and phospholipid profiles in renal cells Biochem. Pharmacol. 70 2005 1697 1706
108. M.A. Masood, R.P. Rao, J.K. Acharya, J. Blonder, and T.D. Veenstra Quantitation of multiple sphingolipid classes using normal and reversed-phase LC-ESI-MS/MS: comparative profiling of two cell lines Lipids 47 2012 209 226
109. M. Mal, P.K. Koh, P.Y. Cheah, and E.C. Chan Ultra-pressure liquid chromatography/tandem mass spectrometry targeted profiling of arachidonic acid and eicosanoids in human colorectal cancer Rapid Commun. Mass Spectrom. 25 2011 755 764
110. B.H. Maskrey, I.L. Megson, A.G. Rossi, and P.D. Whitfield Emerging importance of omega-3 fatty acids in the innate immune response: Molecular mechanisms and lipidomic strategies for their analysis Mol. Nutr. Food Res. 57 2013 1390 1400
111. K.H. Weylandt, L.F. Krause, B. Gomolka, C.Y. Chiu, S. Bilal, A. Nadolny, S.F. Waechter, A. Fischer, M. Rothe, and J.X. Kang Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-α Carcinogenesis 32 2011 897 903
112. L.S. Eberlin, I. Norton, A.L. Dill, A.J. Golby, K.L. Ligon, S. Santagata, R.G. Cooks, and N.Y. Agar Classifying human brain tumors by lipid imaging with mass spectrometry Cancer Res. 72 2012 645 654
113. J.M. Weir, G. Wong, C.K. Barlow, M.A. Greeve, A. Kowalczyk, L. Almasy, A.G. Comuzzie, M.C. Mahaney, J.B. Jowett, J. Shaw, J.E. Curran, J. Blangero, and P.J. Meikle Plasma lipid profiling in a large population-based cohort J. Lipid Res. 54 2013 2898 2908
114. K.H. Pietiläinen, M. Sysi-Aho, A. Rissanen, T. Seppänen-Laakso, H. Yki-Järvinen, J. Kaprio, and M. Oresic Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects-a monozygotic twin study Plos One 2 2007 e218
115. J.M. Haus, S.R. Kashyap, T. Kasumov, R. Zhang, K.R. Kelly, R.A. Defronzo, and J.P. Kirwan Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance Diabetes 58 2009 337 343
116. P.J. Meikle, G. Wong, C.K. Barlow, J.M. Weir, M.A. Greeve, G.L. MacIntosh, L. Almasy, A.G. Comuzzie, M.C. Mahaney, A. Kowalczyk, I. Haviv, N. Grantham, D.J. Magliano, J.B. Jowett, P. Zimmet, J.E. Curran, J. Blangero, and J. Shaw Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes Plos One 8 2013 e74341
117. H. Miao, H. Chen, X. Zhang, L. Yin, D.Q. Chen, X.L. Cheng, X. Bai, and F. Wei Urinary metabolomics on the biochemical profiles in diet-induced hyperlipidemia rat using ultra-performance liquid chromatography coupled with quadrupole time-of-flight synapt high-definition mass spectrometry J. Anal. Methods Chem. 2014 2014 184162
118. M.J. Fletcher A colorimetric method for estimating serum triglycerides Clin. Chim. Acta 22 1968 393 397
119. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053
120. J. Li, C. Romestaing, X. Han, Y. Li, X. Hao, Y. Wu, C. Sun, X. Liu, L.S. Jefferson, J. Xiong, K.F. Lanoue, Z. Chang, C.J. Lynch, H. Wang, and Y. Shi Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity Cell Metab. 12 2010 154 165
121. N. Bijl, M. Sokolović, C. Vrins, M. Langeveld, P.D. Moerland, R. Ottenhoff, C.P. van Roomen, N. Claessen, R.G. Boot, J. Aten, A.K. Groen, J.M. Aerts, and M. van Eijk Modulation of glyco-sphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice Hepatology 50 2009 1431 1441
122. M. van Eijk, J. Aten, N. Bijl, R. Ottenhoff, C.P. van Roomen, P.F. Dubbelhuis, I. Seeman, K. Ghauharali-van der Vlugt, H.S. Overkleeft, C. Arbeeny, A.K. Groen, and J.M. Aerts Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation Plos One 4 2009 e4723
123. S. Cinti, G. Mitchell, G. Barbatelli, I. Murano, E. Ceresi, E. Faloia, S. Wang, M. Fortier, A.S. Greenberg, and M.S. Obin Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans J. Lipid Res. 46 2005 2347 2355
124. J.I. Inokuchi Membrane microdomains and insulin resistance FEBS Lett. 584 2010 1864 1871
125. G. Shui, S.M. Lam, J. Stebbins, J. Kusunoki, X. Duan, B. Li, W.F. Cheong, D. Soon, R.P. Kelly, and M.R. Wenk Polar lipid derangements in type 2 diabetes mellitus: potential pathological relevance of fatty acyl heterogeneity in sphingolipids Metabolomics 9 2013 786 799
126. V.D. de Mello, M. Lankinen, U. Schwab, M. Kolehmainen, S. Lehto, T. Seppänen-Laakso, M. Oresic, L. Pulkkinen, M. Uusitupa, and A.T. Erkkilä Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease Diabetologia 52 2009 2612 2615
127. W.L. Holland, B.T. Bikman, L.P. Wang, G. Yuguang, K.M. Sargent, S. Bulchand, T.A. Knotts, G. Shui, D.J. Clegg, M.R. Wenk, M.J. Pagliassotti, P.E. Scherer, and S.A. Summers Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice J. Clin. Invest. 121 2011 1858 1870
128. A. Kotronen, V.R. Velagapudi, L. Yetukuri, J. Westerbacka, R. Bergholm, K. Ekroos, J. Makkonen, M.R. Taskinen, M. Oresic, and H. Yki-Järvinen Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations Diabetologia 52 2009 684 690
129. S. Tagami, J. Inokuchi Ji, K. Kabayama, H. Yoshimura, F. Kitamura, S. Uemura, C. Ogawa, A. Ishii, M. Saito, Y. Ohtsuka, S. Sakaue, and Y. Igarashi Ganglioside GM3 participates in the pathological conditions of insulin resistance J. Biol. Chem. 277 2002 3085 3092
130. K. Kabayama, T. Sato, K. Saito, N. Loberto, A. Prinetti, S. Sonnino, M. Kinjo, Y. Igarashi, and J. Inokuchi Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance Proc. Natl. Acad. Sci. U. S. A. 104 2007 13678 13683
131. P. Puri, M.M. Wiest, O. Cheung, F. Mirshahi, C. Sargeant, H.K. Min, M.J. Contos, R.K. Sterling, M. Fuchs, H. Zhou, S.M. Watkins, and A.J. Sanyal The plasma lipidomic signature of nonalcoholic steatohepatitis Hepatology 50 2009 1827 1838
132. H. Malhi, S.F. Bronk, N.W. Werneburg, and G.J. Gores Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis J. Biol. Chem. 281 2006 12093 12101
133. H. Cao, K. Gerhold, J.R. Mayers, M.M. Wiest, S.M. Watkins, and G.S. Hotamisligil Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism Cell 134 2008 933 944
134. A. González-Périz, R. Horrillo, N. Ferré, K. Gronert, B. Dong, E. Morán-Salvador, E. Titos, M. Martínez-Clemente, M. López-Parra, V. Arroyo, and J. Clària Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins FASEB J. 23 2009 1946 1957
135. D. Hall, C. Poussin, V.R. Velagapudi, C. Empsen, M. Joffraud, J.S. Beckmann, A.E. Geerts, Y. Ravussin, M. Ibberson, M. Oresic, and B. Thorens Peroxisomal and microsomal lipid pathways associated with resistance to hepatic steatosis and reduced pro-inflammatory state J. Biol. Chem. 285 2010 31011 31023
136. B.R. Culp, B.G. Titus, and W.E. Lands Inhibition of prostaglandin biosynthesis by eicosapentaenoic acid Prostagl. Med. 3 1979 269 278
137. M. López-Parra, E. Titos, R. Horrillo, N. Ferré, A. González-Périz, M. Martínez-Clemente, A. Planagumà, J. Masferrer, V. Arroyo, and J. Clària Regulatory effects of arachidonate 5-lipoxygenase on hepatic MTP activity and VLDL-TG and ApoB secretion in obese mice J. Lipid Res. 49 2008 2513 2523
138. N.T. de Gómez Dumm, A.M. Giammona, L.A. Touceda, and C. Raimondi Lipid abnormalities in chronic renal failure patients undergoing hemodialysis Med. (B Aires) 61 2001 142 146
139. Y.Y. Zhao, Y.L. Feng, X. Bai, X.J. Tan, R.C. Lin, and Q. Mei Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism Plos One 8 2013 e59617
140. Y.Y. Zhao, X.L. Cheng, F. Wei, X. Bai, X.J. Tan, R.C. Lin, and Q. Mei Intrarenal metabolomic investigation of chronic kidney disease and its TGF-β1 mechanism in induced-adenine rats using UPLC Q-TOF/HSMS/MSE J. Proteome Res. 12 2013 692 703
141. Y.Y. Zhao, P. Lei, D.Q. Chen, Y.L. Feng, and X. Bai Renal metabolic profiling of early renal injury and renoprotective effects of poria cocos epidermis using UPLC Q-TOF/HSMS/MSE J. Pharm. Biomed. Anal. 81-82 2013 202 209
142. L. Jia, C. Wang, S. Zhao, X. Lu, and G. Xu Metabolomic identification of potential phospholipid biomarkers for chronic glomerulonephritis by using high performance liquid chromatography-mass spectrometry J. Chromatogr. B 86 2007 134 140
143. Y.Y. Zhao, X.L. Cheng, F. Wei, X.Y. Xiao, W.J. Sun, Y. Zhang, and R.C. Lin Serum metabonomics study of adenine-induced chronic renal failure rat by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry Biomarkers 17 2012 48 55
144. Y.Y. Zhao, X.L. Cheng, J.H. Cui, X.R. Yan, F. Wei, X. Bai, and R.C. Lin Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: A serum metabonomic study based on ultra performance liquid chromatography/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm Clin. Chim. Acta 413 2012 1438 1445
145. Y.Y. Zhao Metabolomics in chronic kidney disease Clin. Chim. Acta 422 2013 59 69
146. C. Zhu, Q.L. Liang, P. Hu, Y.M. Wang, and G.A. Luo Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy Talanta 85 2011 1711 1720
147. L.D. Han, J.F. Xia, Q.L. Liang, Y. Wang, Y.M. Wang, P. Hu, P. Li, and G.A. Luo Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography-mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy Anal. Chim. Acta 689 2011 85 91
148. I.R. Hassan, and K. Gronert Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1 J. Immunol. 182 2009 3223 3232
149. J. Graessler, D. Schwudke, P.E. Schwarz, R. Herzog, A. Shevchenko, and S.R. Bornstein Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients Plos One 4 2009 e6261
150. C. Hu, H. Kong, F. Qu, Y. Li, Z. Yu, P. Gao, S. Peng, and G. Xu Application of plasma lipidomics in studying the response of patients with essential hypertension to antihypertensive drug therapy Mol. Biosyst. 7 2011 3271 3279
151. G. Stübiger, E. Aldover-Macasaet, W. Bicker, G. Sobal, A. Willfort-Ehringer, K. Pock, V. Bochkov, K. Widhalm, and O. Belgacem Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using MALDI-QIT-TOF-MS/MS Atherosclerosis 224 2012 177 186
152. U. Schwab, T. Seppänen-Laakso, L. Yetukuri, J. Agren, M. Kolehmainen, D.E. Laaksonen, A.L. Ruskeepää, H. Gylling, M. Uusitupa, and M. Oresic Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism-the GENOBIN study Plos One 3 2008 e2630
153. P.J. Meikle, G. Wong, D. Tsorotes, C.K. Barlow, J.M. Weir, M.J. Christopher, G.L. MacIntosh, B. Goudey, L. Stern, A. Kowalczyk, I. Haviv, A.J. White, A.M. Dart, S.J. Duffy, G.L. Jennings, and B.A. Kingwell Plasma lipidomic analysis of stable and unstable coronary artery disease Arterioscler. Thromb. Vasc. Biol. 31 2011 2723 2732
154. C. Stegemann, I. Drozdov, J. Shalhoub, J. Humphries, C. Ladroue, A. Didangelos, M. Baumert, M. Allen, A.H. Davies, C. Monaco, A. Smith, Q. Xu, and M. Mayr Comparative lipidomics profiling of human atherosclerotic plaques Circ. Cardiovasc. Genet. 4 2011 232 242
155. C. Pettinella, S.H. Lee, F. Cipollone, and I.A. Blair Targeted quantitative analysis of fatty acids in atherosclerotic plaques by high sensitivity liquid chromatography/tandem mass spectrometry J. Chromatogr. B 850 2007 168 176
156. J.T. Salonen, K. Nyyssonen, R. Salonen, E. Porkkala-Sarataho, T.P. Tuomainen, U. Diczfalusy, and I. Björkhem Lipoprotein oxidation and progression of carotid atherosclerosis Circulation 95 1997 840 845
157. E.A. Podrez, T.V. Byzova, M. Febbraio, R.G. Salomon, Y. Ma, M. Valiyaveettil, E. Poliakov, M. Sun, P.J. Finton, B.R. Curtis, J. Chen, R. Zhang, R.L. Silverstein, and S.L. Hazen Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype Nat. Med. 13 2007 1086 1095
158. B. Davis, G. Koster, L.J. Douet, M. Scigelova, G. Woffendin, J.M. Ward, A. Smith, J. Humphries, K.G. Burnand, C.H. Macphee, and A.D. Postle Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein J. Biol. Chem. 283 2008 6428 6437
159. P.M. Hutchins, E.E. Moore, and R.C. Murphy Electrospray MS/MS reveals extensive and nonspecific noxidation of cholesterol esters in human peripheral vascular lesions J. Lipid Res. 52 2011 2070 2083
160. S. Mas, R. Martínez-Pinna, J.L. Martín-Ventura, R. Pérez, D. Gomez-Garre, A. Ortiz, A. Fernandez-Cruz, F. Vivanco, and J. Egido Local non-esterified fatty acids correlate with inflammation in atheroma plaques of patients with type 2 diabetes Diabetes 59 2010 1292 1301
161. M. Ollero, I.C. Guerrera, G. Astarita, D. Piomelli, and A. Edelman New lipidomic approaches in cystic fibrosis Methods Mol. Biol. 742 2011 265 278
162. I.C. Guerrera, G. Astarita, J.P. Jais, D. Sands, A. Nowakowska, J. Colas, I. Sermet-Gaudelus, M. Schuerenberg, D. Piomelli, A. Edelman, and M. Ollero A novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients Plos One 4 2009 e7735
163. M. Ollero, G. Astarita, I.C. Guerrera, I. Sermet-Gaudelus, S. Trudel, D. Piomelli, and A. Edelman Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients J. Lipid Res. 52 2011 1011 1022
164. N. Desbenoit, E. Saussereau, C. Bich, M. Bourderioux, J. Fritsch, A. Edelman, A. Brunelle, and M. Ollero Localized lipidomics in cystic fibrosis: TOF-SIMS imaging of lungs from Pseudomonas aeruginosa-infected mice Int. J. Biochem. Cell Biol. 52 2014 77 82
165. E.D. Telenga, R.F. Hoffmann, t'Kindt Ruben, S.J. Hoonhorst, B.W. Willemse, A.J. van Oosterhout, I.H. Heijink, M. van den Berge, L. Jorge, P. Sandra, D.S. Postma, K. Sandra, and N.H. ten Hacken Untargeted lipidomic analysis in chronic obstructive pulmonary disease. Uncovering sphingolipids Am. J. Respir. Crit. Care Med. 190 2014 155 164
166. S.L. Lundström, D. Balgoma, Å.M. Wheelock, J.Z. Haeggström, S.E. Dahlén, and C.E. Wheelock Lipid mediator profiling in pulmonary disease Curr. Pharm. Biotechnol. 12 2011 1026 1052
167. K. Syslová, P. Kačer, B. Vilhanová, M. Kuzma, P. Lipovová, Z. Fenclová, J. Lebedová, and D. Pelclová Determination of cysteinyl leukotrienes in exhaled breath condensate: method combining immunoseparation with LC-ESI-MS/MS J. Chromatogr. B 879 2011 2220 2228
168. L.G. Fritscher, M. Post, M.T. Rodrigues, F. Silverman, M. Balter, K.R. Chapman, and N. Zamel Profile of eicosanoids in breath condensate in asthma and COPD J. Breath. Res. 6 2012 026001
169. N. Higashi, H. Mita, E. Ono, Y. Fukutomi, H. Yamaguchi, K. Kajiwara, H. Tanimoto, K. Sekiya, K. Akiyama, and M. Taniguchi Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers J. Allergy Clin. Immunol. 125 2010 1084 1091
170. M. Sanak, A. Gielicz, G. Bochenek, M. Kaszuba, E. Nizankowska-Mogilnicka, and A. Szczeklik Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype J. Allergy Clin. Immunol. 127 2011 1141 1147
171. V. Goss, A.N. Hunt, and A.D. Postle Regulation of lung surfactant phospholipid synthesis and metabolism Biochim. Biophys. Acta-Mol. Cell Bio. Lip 1831 2013 448 458
172. I. Batal, M.B. Ericsoussi, J.E. Cluette-Brown, B.P. O'Sullivan, S.D. Freedman, J.E. Savaille, and M. Laposata Potential utility of plasma fatty acid analysis in the diagnosis of cystic fibrosis Clin. Chem. 53 2007 78 84
173. P. Risé, S. Volpi, C. Colombo, R.F. Padoan, C. D'Orazio, S. Ghezzi, P. Melotti, V. Bennato, C. Agostoni, B.M. Assael, and C. Galli Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease J. Cyst. Fibros. 9 2010 228 233
174. Y.P. Kang, W.J. Lee, J.Y. Hong, S.B. Lee, J.H. Park, D. Kim, S. Park, C.S. Park, S.W. Park, and S.W. Kwon Novel approach for analysis of bronchoalveolar lavage fluid (BALF) using HPLC-QTOF-MS-based lipidomics: lipid levels in asthmatics and corticosteroid-treated asthmatic patients J. Proteome Res. 13 2014 3919 3929
175. Y.P. van der Meer-Janssen, J. van Galen, J.J. Batenburg, and J.B. Helms Lipids in host-pathogen interactions: pathogens exploit the complexity of the host cell lipidome Prog. Lipid Res. 49 2010 1 26
176. R.C. Aloia, H. Tian, and F.C. Jensen Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes Proc. Natl. Acad. Sci. U. S. A. 90 1993 5181 5185
177. R. Chan, P.D. Uchil, J. Jin, G. Shui, D.E. Ott, W. Mothes, and M.R. Wenk Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides J. Virol. 82 2008 11228 11238
178. J.S. Saad, J. Miller, J. Tai, A. Kim, R.H. Ghanam, and M.F. Summers Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly Proc. Natl. Acad. Sci. U. S. A. 103 2006 11364 11369
179. K.L. Low, P.S. Rao, G. Shui, A.K. Bendt, K. Pethe, T. Dick, and M.R. Wenk Triacylglycerol utilization is required for regrowth of in vitro hypoxic nonreplicating Mycobacterium bovis bacillus Calmette-Guerin J. Bacteriol. 191 2008 5037 5043
180. K.L. Low, G. Shui, K. Natter, W.K. Yeo, S.D. Kohlwein, T. Dick, S.P. Rao, and M.R. Wenk Lipid droplet-associated proteins are involved in the biosynthesis and hydrolysis of triacylglycerol in Mycobacterium bovis bacillus Calmette-Guerin J. Biol. Chem. 285 2010 21662 21670
181. V.C. Tam, O. Quehenberger, C.M. Oshansky, R. Suen, A.M. Armando, P.M. Treuting, P.G. Thomas, E.A. Dennis, and A. Aderem Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation Cell 154 2013 213 227
182. L.B. Tanner, C. Chng, X.L. Guan, Z. Lei, S.G. Rozen, and M.R. Wenk Lipidomics identifies a requirement for peroxisomal function during influenza virus replication J. Lipid Res. 55 2014 1357 1365